PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,302	3,481	2,080	2,786	2,816	4,164
Market Cap Growth	85.59%	67.40%	-25.35%	-1.06%	-32.38%	40.68%
Enterprise Value	7,087	4,940	3,253	3,671	3,207	4,102
Last Close Price	78.50	45.14	27.56	38.17	39.83	61.03
PS Ratio	3.45	4.32	2.22	3.99	5.23	10.94
PB Ratio	-	-3.17	-2.54	-8.03	1958.20	8.64
EV/Sales Ratio	3.98	6.12	3.47	5.25	5.95	10.77
Debt / Equity Ratio	-16.00	-2.25	-2.72	-4.21	882.73	2.28
Asset Turnover	0.79	0.45	0.52	0.38	0.26	0.20
Inventory Turnover	11.39	22.02	27.95	36.97	33.17	23.33
Quick Ratio	2.21	2.26	1.90	1.39	1.74	4.23
Current Ratio	2.32	2.35	2.02	1.71	1.87	4.44
Return on Equity (ROE)	-	-	-	-	-216.75%	-81.42%
Return on Assets (ROA)	25.70%	-5.09%	-12.13%	-15.09%	-11.30%	-11.21%
Return on Capital (ROIC)	30.63%	-6.59%	-17.30%	-23.05%	-16.43%	-17.15%
Return on Capital Employed (ROCE)	51.90%	-13.10%	-27.00%	-33.90%	-26.20%	-17.80%
Earnings Yield	11.93%	-10.44%	-30.13%	-20.06%	-18.61%	-10.52%
FCF Yield	11.19%	-3.28%	-8.98%	-13.95%	-9.93%	-5.09%
Buyback Yield / Dilution	-10.56%	-2.68%	-4.33%	-1.79%	-6.72%	-12.17%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q